drugset / Trial / NCT03362424

Mesenchymal Stem Cells in Rotator Cuff Repair

NCT03362424

Phase 2 Suspended 44 enrolled University of Sao Paulo
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized clinical study involving 44 patients, evaluating the effect of mesenchymal cells on rotator cuff repair. The primary outcome will be post-operative MRI tendon integrity and secondary outcomes clinical assessment by the UCLA and American Shoulder and Elbow Surgeons (ASES) scales and pain by visual analog scale (VAS).

Timeline

Start
2020-11-01
Primary completion
2023-12-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal stem cell Cell therapy